Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Winrow

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Oiling the pipeline: the path from genomics to drug discovery for brain diseaseChristopher J Winrow, Carrolee Barlow
Annual Review of Pharmacology and Toxicology|November 2, 2010
Orexin receptors: pharmacology and therapeutic opportunitiesThomas E Scammell, Christopher J Winrow
Idrugs : the Investigational Drugs Journal|November 7, 2008
Genetic approaches for target identification in sleep/wake systemsChristopher J Winrow, Fred W Turek, John J Renger
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2003
Evidence that mouse brain neuropathy target esterase is a lysophospholipaseGary B Quistad, Carrolee Barlow, Christopher J Winrow, et al.
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Journal of Molecular Neuroscience : MN|April 10, 2007
Distribution of histone deacetylases 1-11 in the rat brainRon S Broide, Jeff M Redwine, Najla Aftahi, et al.
Nature Genetics|March 18, 2003
Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivityChristopher J Winrow, Matthew L Hemming, Duane M Allen, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Behavioural Brain Research|June 15, 2018
Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memoryDarrell Eacret, Laura A Grafe, Jane Dobkin, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Oiling the pipeline: the path from genomics to drug discovery for brain diseaseChristopher J Winrow, Carrolee Barlow
Annual Review of Pharmacology and Toxicology|November 2, 2010
Orexin receptors: pharmacology and therapeutic opportunitiesThomas E Scammell, Christopher J Winrow
Idrugs : the Investigational Drugs Journal|November 7, 2008
Genetic approaches for target identification in sleep/wake systemsChristopher J Winrow, Fred W Turek, John J Renger
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2003
Evidence that mouse brain neuropathy target esterase is a lysophospholipaseGary B Quistad, Carrolee Barlow, Christopher J Winrow, et al.
Annual Review of Pharmacology and Toxicology|November 19, 2016
The Discovery of Suvorexant, the First Orexin Receptor Drug for InsomniaPaul J Coleman, Anthony L Gotter, W Joseph Herring, et al.
Pharmacological Reviews|July 5, 2012
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacologyAnthony L Gotter, Andrea L Webber, Paul J Coleman, et al.
Journal of Molecular Neuroscience : MN|April 10, 2007
Distribution of histone deacetylases 1-11 in the rat brainRon S Broide, Jeff M Redwine, Najla Aftahi, et al.
Nature Genetics|March 18, 2003
Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivityChristopher J Winrow, Matthew L Hemming, Duane M Allen, et al.
Progress in Brain Research|July 21, 2012
Orexin receptors as therapeutic drug targetsAnthony L Gotter, Anthony J Roecker, Richard Hargreaves, et al.
Behavioural Brain Research|June 15, 2018
Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memoryDarrell Eacret, Laura A Grafe, Jane Dobkin, et al.
Pageof 6